Treatment of persistent coronavirus disease 2019 (COVID-19) in a B cell acute lymphoblastic leukemia patient with using nirmatrelvir/ritonavir extended course: A case report

Hassan Almarhabi; Aisha Alharbi; Mai Alalawi; Mohamed Firoze Ahamed; Ihab El-Hemaidi; Nader Damfu

Journal of Infection and Public Health (Oct 2024)

Treatment of persistent coronavirus disease 2019 (COVID-19) in a B cell acute lymphoblastic leukemia patient with using nirmatrelvir/ritonavir extended course: A case report

Hassan Almarhabi,
Aisha Alharbi,
Mai Alalawi,
Mohamed Firoze Ahamed,
Ihab El-Hemaidi,
Nader Damfu

Affiliations

Hassan Almarhabi: Department of Medicine, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Jeddah, Saudi Arabia; King Abdullah International Medical Research Center, Jeddah, Saudi Arabia; King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia
Aisha Alharbi: King Abdullah International Medical Research Center, Jeddah, Saudi Arabia; King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia; Pharmaceutical Care Department, King Abdulaziz Medical City, Jeddah, Saudi Arabia; Corresponding author at: Pharmaceutical Care Department, King Abdulaziz Medical City, PO Box 9515, Jeddah 21423, Saudi Arabia.
Mai Alalawi: King Abdullah International Medical Research Center, Jeddah, Saudi Arabia; King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia; Pharmaceutical Care Department, King Abdulaziz Medical City, Jeddah, Saudi Arabia
Mohamed Firoze Ahamed: Consultant Radiologist, Medical Imaging Department, King Abdulaziz Medical City, Jeddah, Saudi Arabia
Ihab El-Hemaidi: King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia; Consultant Adult Hematology/BMT, Princess Norah Oncology Center, Jeddah, Saudi Arabia
Nader Damfu: King Abdullah International Medical Research Center, Jeddah, Saudi Arabia; King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia; Infection Prevention and Control Department, King Abdulaziz Medical City, Ministry of National Guard Health Affairs (MNGHA), Jeddah, Saudi Arabia

Journal volume & issue: Vol. 17, no. 10
p. 102526

Abstract

Read online

Patients with hematological malignancies are at increased risk of persistent coronavirus disease 2019 (COVID-19) infection, a unique clinical condition, for which the optimal treatment is unknown. Here we report a case of persistent COVID-19 in acute lymphoblastic leukemia (ALL) patient who successfully responded to extended course nirmatrelvir/ritonavir.

Published in Journal of Infection and Public Health

ISSN: 1876-0341 (Print); 1876-035X (Online)
Publisher: Elsevier
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Infectious and parasitic diseases; Medicine: Public aspects of medicine
Website: https://www.journals.elsevier.com/journal-of-infection-and-public-health

About the journal

Abstract

Keywords